Showing posts with label dementia. Show all posts
Showing posts with label dementia. Show all posts
Monday, October 22, 2018
Antipsychotic Drugs Will Not Avert Delirium Or Dementia Sugar Pill Will Work Better
A recent study major study found that anti-psychotic drugs such as haloperidol branded as Haldol are no more effective than a placebo for treating delirium or dementia. This is a similar study where anti-psychotics are no better than a placebo to avert depression.
Powerful drugs that have been used for decades to treat delirium are ineffective for that purpose are useless according to the New England Journal of Medicine. Many doctors in higher end medical facilities prescribe these drugs in intensive care units and emergency rooms across the nation. Millions worldwide are getting these drugs to combat delirium and they have zero effectiveness. This is why we call this Pharma Fraud. Insurance firms and patients are paying top dollar for products that do not work and have never worked.
Patients with delirium are often confused and incoherent and sometimes can suffer hallucinations. This can lead to long term issues. condition can lead to long-term cognitive problems, including a form of dementia.
We hope patients and insurance companies will sue these firms for fraud. Finally a study which is not stirred for pharma, but for the real truth.
Thursday, November 2, 2017
Psychiatry and Pharmaceutical Companies Targeting Grandma
This is a report from CNN of all networks. This is a surprise since broadcast firms rely so much on pharmaceutical advertising that they almost never report on their crimes.
This report does involves Nuedexta, which is approved for patients with uncontrollable laughing or crying which is known as pseudobulbar affect, or PBA. It is a condition that only affects 1% of the population. The drug had been initially targeted for people with multiple sclerosis and ALS or Lou Gehrig’s disease.
CNN in their report indicated a California psychiatrist Romeo Isidro had received hundreds of thousands of dollars in promotional payments from Avanir the maker of Neudexta. Apparently 50% of Nuedexta’s sales have gone to dementia patients and patients with Alzheimer’s disease. Sales have since jumped 400% and made $300 million in 2016.
According to the pharma company Avanir, they say 40% of people with dementia are afflicted with PBA, but this has been disputed by many experts. The actual test that produced the 40% afflicted rate was funded by the drug producer Avanir. We smell a rat do you?
The rat has a keeper and that keeper has no gate. It is the FDA. Nuedexta is approved by the Food and Drug Administration (FDA) to treat anyone with PBA. This entitles Avanir to include those with neurological conditions like dementia. Yet most responsible geriatric physicians say PBA affects less than 5% of all patients with dementia.
In CNN’s report a Los Angeles nursing home last year, regulators found that more than a quarter of its residents 46 of 162 had been placed on Nuedexta, noting that a facility psychiatrist had given a talk about the drug to employees. This psychiatrist was a paid speaker fee from Avanir. End CNN’s report
Do you see the direct correlation between drug companies and psychiatrists? It’s all about money and nothing about patient care. Pharma funds a front research group to get the result they want. The FDA is run by psychiatrists, so they approve those research reports, and people die.
If you’re elder parents or grandparents are in a long term care facility. You need to stand up to their caregiver. Your parent stood up for you on the playground. Fight the insanity by getting involved in your elderly parents last years.
This report does involves Nuedexta, which is approved for patients with uncontrollable laughing or crying which is known as pseudobulbar affect, or PBA. It is a condition that only affects 1% of the population. The drug had been initially targeted for people with multiple sclerosis and ALS or Lou Gehrig’s disease.
CNN in their report indicated a California psychiatrist Romeo Isidro had received hundreds of thousands of dollars in promotional payments from Avanir the maker of Neudexta. Apparently 50% of Nuedexta’s sales have gone to dementia patients and patients with Alzheimer’s disease. Sales have since jumped 400% and made $300 million in 2016.
According to the pharma company Avanir, they say 40% of people with dementia are afflicted with PBA, but this has been disputed by many experts. The actual test that produced the 40% afflicted rate was funded by the drug producer Avanir. We smell a rat do you?
The rat has a keeper and that keeper has no gate. It is the FDA. Nuedexta is approved by the Food and Drug Administration (FDA) to treat anyone with PBA. This entitles Avanir to include those with neurological conditions like dementia. Yet most responsible geriatric physicians say PBA affects less than 5% of all patients with dementia.
In CNN’s report a Los Angeles nursing home last year, regulators found that more than a quarter of its residents 46 of 162 had been placed on Nuedexta, noting that a facility psychiatrist had given a talk about the drug to employees. This psychiatrist was a paid speaker fee from Avanir. End CNN’s report
Do you see the direct correlation between drug companies and psychiatrists? It’s all about money and nothing about patient care. Pharma funds a front research group to get the result they want. The FDA is run by psychiatrists, so they approve those research reports, and people die.
If you’re elder parents or grandparents are in a long term care facility. You need to stand up to their caregiver. Your parent stood up for you on the playground. Fight the insanity by getting involved in your elderly parents last years.
Subscribe to:
Posts (Atom)